Mission & Story
Mission
To make hemodynamic insights non-invasive, accessible, and actionable for every healthcare professional caring for people with heart failure
Founding Story
Founded in 2019 by Filip Peters (CEO) who has a background in machine learning applied to time-series data in finance. Peters saw the opportunity to transfer advanced analytical techniques into healthcare, developing the patented SAVE Sensor System to provide accurate cardiac and pulmonary pressure insights without catheterization.
Clinical Focus
Medical conditions and clinical areas addressed by Acorai.
Who It Serves
Milestones & Awards
Recent Milestones
Clinically tested in over 2000 patients across 20 hospitals in 6 countries. FDA Breakthrough Device Designation granted. Planning Research Use Only device availability in 2026. Targeting FDA clearance in 2027.
Awards & Recognition
FDA Breakthrough Device Designation, EIT Health Gold Track program participant
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Caption Health, Inc
Caption Health develops AI-powered ultrasound guidance technology that enables healthcare providers to capture high-quality cardiac ultrasound images, expanding access to diagnostic imaging beyond traditional specialists.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.